EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Cardinal Health's enterprise value is $26,447 Mil.
Cardinal Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $1,892 Mil. Therefore, Cardinal Health's EV-to-EBITDA for today is 13.98.
The historical rank and industry rank for Cardinal Health's EV-to-EBITDA or its related term are showing as below:
CAH'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -119.88 Med: 11.32 Max: 277.52
Current: 13.98
During the past 13 years, the highest EV-to-EBITDA of Cardinal Health was 277.52. The lowest was -119.88. And the median was 11.32.
CAH's EV-to-EBITDA is ranked worse than 72.84% of 81
companies
in the Medical Distribution industry
Industry Median: 10.01
vs CAH: 13.98
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-20), Cardinal Health's stock price is $108.19.
Cardinal Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $2.540. Therefore, Cardinal Health's PE Ratio for today is 42.59.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Cardinal Health EV-to-EBITDA Historical Data
The historical data trend for Cardinal Health's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Cardinal Health Annual Data
Trend
Jun14
Jun15
Jun16
Jun17
Jun18
Jun19
Jun20
Jun21
Jun22
Jun23
EV-to-EBITDA
6.43
-7.36
15.12
206.54
17.14
Cardinal Health Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
EV-to-EBITDA
34.10
15.43
17.14
17.44
13.04
Competitive Comparison
For the Medical Distribution subindustry, Cardinal Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cardinal Health EV-to-EBITDA Distribution
For the Medical Distribution industry and Healthcare sector, Cardinal Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Cardinal Health's EV-to-EBITDA falls into.
Cardinal Health EV-to-EBITDA Calculation
Cardinal Health's EV-to-EBITDA for today is calculated as:
Cardinal Health's current Enterprise Value is $26,447 Mil.
Cardinal Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,892 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cardinal Health (NYSE:CAH) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Cardinal Health's PE Ratio for today is calculated as:
Cardinal Health's share price for today is $108.19.
Cardinal Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.540.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Cardinal Health's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Cardinal Health (Cardinal Health) Business Description
Cardinal Health is one of three leading pharmaceutical wholesalers in the U.S., engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and McKesson, the three comprise well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CAH has been successfully added to your 